Paediatric safety assessment of BNT162b2 vaccination in a multistate hospital-based electronic health record system in the USA: a retrospective analysis

Summary: Background: The emergency use authorisation of BNT162b2 (tozinameran; Comirnaty, Pfizer–BioNTech) for children aged 5–17 years has resulted in rapid vaccination in the paediatric population. However, there are few studies of adverse events associated with vaccination in children. The aim o...

Full description

Bibliographic Details
Main Authors: Robert P Matson, BS, Michiel J M Niesen, PhD, Emily R Levy, MD, Derek N Opp, DO, Patrick J Lenehan, PhD, Greg Donadio, MA, John C O'Horo, ProfMD, A J Venkatakrishnan, PhD, Andrew D Badley, ProfMD, Venky Soundararajan, PhD
Format: Article
Language:English
Published: Elsevier 2023-04-01
Series:The Lancet: Digital Health
Online Access:http://www.sciencedirect.com/science/article/pii/S2589750022002539